AI Analysis AI Analysis of IMRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IMRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

A very strong day for Immuneering Corporation stock price on Wednesday
(Updated on Jun 17, 2026)

Hold candidate since Jun 17, 2026

The Immuneering Corporation stock price gained 7.56% on the last trading day (Wednesday, 17th Jun 2026), rising from $4.10 to $4.41. During the last trading day the stock fluctuated 9.25% from a day low at $4.16 to a day high of $4.55. The price has fallen in 5 of the last 10 days and is down by -3.08% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 740 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $8.22 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.95% during the next 3 months and, with a 90% probability hold a price between $3.23 and $4.62 at the end of this 3-month period.

IMRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 12.50%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Immuneering Corporation stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.86. On a fall, the stock will find some support from the short-term average at $4.14. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Immuneering Corporation stock

Immuneering Corporation finds support from accumulated volume at $4.28 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.385 between high and low, or 9.25%. For the last week, the stock has had daily average volatility of 6.87%.

Our recommended stop-loss: $4.23 (-4.16%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (IMRX) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Immuneering Corporation to open at $4.37, and during the day (based on 14 day Average True Range), to move between $4.22 and $4.60, which gives a possible trading interval of +/-$0.385 (+/-9.12%) up or down from last closing price. If Immuneering Corporation takes out the full calculated possible swing range there will be an estimated 9.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.50 (1.93%) than the support at $4.28 (2.95%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immuneering Corporation stock A Buy?

Immuneering Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.837 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 18, 2026 - $4.37 ( 0.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IMRX Performance

Trading levels for IMRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.76 7.86%
R2 4.61 4.53%
R1 4.52 2.47%
Price 4.41
S1 4.22 -4.20%
S2 4.13 -6.26%
S3 3.99 -9.60%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.39 22.22%
R2 5.02 13.83%
R1 4.50 1.93%
Price 4.41
S1 4.28 -2.95%
S2 4.19 -4.99%
S3 4.12 -6.58%

FAQ

What is the symbol for Immuneering Corporation Stock and on which exchange is it traded?
The symbol for Immuneering Corporation is IMRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immuneering Corporation Stock?
Immuneering Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Immuneering Corporation Stock?
Immuneering Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immuneering Corporation Stock.

What's the current price of Immuneering Corporation Stock?
As of the end of day on the Jun 17, 2026, the price of an Immuneering Corporation (IMRX) share was $4.41.

What is the 52-week high and low for Immuneering Corporation Stock?
The 52-week high for Immuneering Corporation Stock is $10.07 and the 52-week low is $1.68.

What is the market capitalization of Immuneering Corporation Stock?
As of the Jun 17, 2026, the market capitalization of Immuneering Corporation is 160.093M.

When is the next earnings date for Immuneering Corporation?
The upcoming earnings date for Immuneering Corporation is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT IMMUNEERING CORPORATION
Immuneering
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE